journal article·2021-04

Magneto‐Electrically Enhanced Intracellular Catalysis of FePt‐FeC Heterostructures for Chemodynamic Therapy

Huilin Zhang, Jinjin Li, Yang Chen, Jiyue Wu, Kun Wang, Lijie Chen, Ya Wang, Xingwu Jiang, Yanyan Liu, Yelin Wu, Dayong Jin, Wenbo Bu

Advanced Materials· Volume 33· Issue 17
Publisher page

Abstract

Abstract Intracellular catalytic reactions can tailor tumor cell plasticity toward high‐efficiency treatments, but the application is hindered by the low efficiency of intracellular catalysis. Here, a magneto‐electronic approach is developed for efficient intracellular catalysis by inducing eddy currents of FePt‐FeC heterostructures in mild alternating magnetic fields (frequency of f = 96 kHz and amplitude of B ≤ 70 mT). Finite element simulation shows a high density of induced charges gathering at the interface of FePt‐FeC heterostructure in the alternating magnetic field. As a result, the concentration of an essential coenzyme—β‐nicotinamide adenine dinucleotide—in cancer cells is significantly reduced by the enhanced catalytic hydrogenation reaction of FePt‐FeC heterostructures under alternating magnetic stimulation, leading to over 80% of senescent cancer cells—a vulnerable phenotype that facilitates further treatment. It is further demonstrated that senescent cancer cells can be efficiently killed by the chemodynamic therapy based on the enhanced Fenton‐like reaction. By promoting intracellular catalytic reactions in tumors, this approach may enable precise catalytic tumor treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Quantum Dots Synthesis And Properties · Gold and Silver Nanoparticles Synthesis and Applications · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shanghai Key Laboratory of Green Chemistry and Chemical Processes School of Chemistry and Molecular Engineering East China Normal University Shanghai 200062 China

Department of Materials Science Fudan University Shanghai 200433 China

Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development School of Chemistry and Molecular Engineering East China Normal University Shanghai 200062 China

Tongji University Cancer Center Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai 200072 P. R. China

Institute for Biomedical Materials & Devices (IBMD) Faculty of Science University of Technology Sydney New South Wales 2007 Australia

Funding

National Natural Science Foundation of China

References (47)

Show source-provided references
1. 10.1038/s41586-018-0073-710.1038/s41586-018-0073-7 ↗
2. 10.15283/ijsc1809610.15283/ijsc18096 ↗
3. 10.1038/s41586-019-1607-310.1038/s41586-019-1607-3 ↗
4. Yang G. J. · Cancers · 2019 · 11 · 15
5. 10.1016/S0092-8674(02)00734-110.1016/S0092-8674(02)00734-1 ↗
6. 10.1016/j.tcb.2011.11.00610.1016/j.tcb.2011.11.006 ↗
7. 10.1038/s41556-019-0287-410.1038/s41556-019-0287-4 ↗
8. 10.1126/science.aac485410.1126/science.aac4854 ↗
9. 10.1039/b800260f10.1039/b800260f ↗
10. 10.1016/j.apcatb.2020.11959310.1016/j.apcatb.2020.119593 ↗
11. 10.1002/anie.20110118210.1002/anie.201101182 ↗
12. 10.1021/ar50082a00610.1021/ar50082a006 ↗
13. 10.1002/advs.20180027110.1002/advs.201800271 ↗
14. 10.1002/adma.20200156610.1002/adma.202001566 ↗
15. 10.1002/adma.20180230910.1002/adma.201802309 ↗
16. 10.1038/natrevmats.2016.3410.1038/natrevmats.2016.34 ↗
17. 10.1038/nnano.2015.34010.1038/nnano.2015.340 ↗
18. 10.1002/adma.20180482810.1002/adma.201804828 ↗
19. 10.1126/science.aav430210.1126/science.aav4302 ↗
20. 10.1103/PhysRevB.79.19542510.1103/PhysRevB.79.195425 ↗
21. 10.1021/acs.nanolett.6b0410710.1021/acs.nanolett.6b04107 ↗
22. 10.1016/j.nantod.2020.10098810.1016/j.nantod.2020.100988 ↗
23. 10.1038/s41565-019-0606-810.1038/s41565-019-0606-8 ↗
24. 10.1063/1.489145510.1063/1.4891455 ↗
25. 10.1088/0268-1242/24/8/08501310.1088/0268-1242/24/8/085013 ↗
26. Pu K. · Angew. Chem., Int. Ed. · 2020
27. Westgard J. B. · 1997 · 1
28. 10.1080/1478643100365918010.1080/14786431003659180 ↗
29. 10.1039/C6NH00173D10.1039/C6NH00173D ↗
30. 10.1039/C6SC01819J10.1039/C6SC01819J ↗
31. 10.1021/acsnano.7b0446110.1021/acsnano.7b04461 ↗
32. 10.1016/j.nantod.2010.08.00610.1016/j.nantod.2010.08.006 ↗
33. 10.1002/adma.20100369510.1002/adma.201003695 ↗
34. 10.1002/adma.20160363210.1002/adma.201603632 ↗
35. 10.1021/acsnano.5b0804510.1021/acsnano.5b08045 ↗
36. 10.1021/acs.analchem.8b0555210.1021/acs.analchem.8b05552 ↗
37. 10.1038/nrc334010.1038/nrc3340 ↗
38. 10.1042/CBI2009039810.1042/CBI20090398 ↗
39. 10.1021/acsnano.9b0030010.1021/acsnano.9b00300 ↗
40. 10.1016/j.cell.2004.05.00810.1016/j.cell.2004.05.008 ↗
41. 10.1039/C8MH01176A10.1039/C8MH01176A ↗
42. 10.1002/adfm.20190836510.1002/adfm.201908365 ↗
43. 10.1002/anie.20180566410.1002/anie.201805664 ↗
44. 10.1002/anie.20151003110.1002/anie.201510031 ↗
45. 10.1007/s00396-010-2256-010.1007/s00396-010-2256-0 ↗
46. 10.1016/j.semcancer.2017.03.00110.1016/j.semcancer.2017.03.001 ↗
47. 10.1158/0008-5472.CAN-12-279610.1158/0008-5472.CAN-12-2796 ↗